Filing Details
Zymeworks Inc. (NASDAQ:ZYME) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event.
8k filedNASDAQ:ZYME
Zymeworks Inc. (ZYME) Reports Material Event to SEC
Filing Details Zymeworks Inc. (NASDAQ:ZYME) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event. Market Context Zymeworks…
Market Context
Zymeworks Inc.'s stock currently trades at $24.10 with a market capitalization of $1.9B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Zymeworks Inc.'s stock.
All SEC filings for Zymeworks Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ZYME Stock Page
Frequently Asked Questions
Where can I read ZYME's SEC filings?
Browse all filings on our ZYME SEC filings page.
What types of SEC filings does Zymeworks Inc. file?
Public companies like Zymeworks Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.